🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immune checkpoint inhibitors (ICI) have revolutionized the management of ad...
Status
Active Not Recruiting
Location
Institut de Cancerologie de l'Ouest , medical oncology department
Start Date
2025-10-01
Trial ID
NCT06790706
Treatments Being Tested
This randomized phase 2 open-label study will evaluate the safety and effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-28
Trial ID
NCT04262856
Treatments Being Tested
The primary objective of this study is to compare the effect of zimberelima...
Status
Active Not Recruiting
Location
Innovative Clinical Research Institute
Start Date
2022-10-12
Trial ID
NCT05502237
Treatments Being Tested
This is a phase 2 study to evaluate zimberelimab (AB122) combined with domv...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-02-08
Trial ID
NCT04736173
Treatments Being Tested
The main objective of this trial is to evaluate the efficacy of the combo S...
Status
Active Not Recruiting
Location
Hospital Duran i Reynals (ICO L´Hospitalet)
Start Date
2025-01-20
Trial ID
NCT06133517
Treatments Being Tested
The ADJUNCT is a single-arm, phase II clinical trial to evaluate the safety...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07134556
Treatments Being Tested
Master protocol: The main goal of this master clinical study is to evaluate...
Status
Active Not Recruiting
Location
Siteman Cancer Center
Start Date
2025-02-18
Trial ID
NCT06727565
Treatments Being Tested
A phase II study of peri-operative anti-PD1 (Zimberelimab) +/- anti-TIGIT (...
Status
Suspended
Location
Addenbrooke's Hospital
Start Date
2025-02-20
Trial ID
NCT06250036
Treatments Being Tested
The goal of this platform clinical trial is to test how well novel treatmen...
Status
Active Not Recruiting
Location
Arizona Oncology Associates,Substudy-02
Start Date
2023-03-16
Trial ID
NCT05633667
This study is being done to test the safety and effectiveness of combining ...
Status
Suspended
Location
Dana Farber Cancer Institute
Start Date
2022-11-30
Trial ID
NCT05419479
Treatments Being Tested